arrow
S

Simon C. Satchell

University of Bristol
H指数:51
被引数:9,541

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease

肝素酶抑制可防止实验性微小病变肾病中的糖萼损伤和蛋白尿

2026-05-310
OAAI
Autoantibodies reactive with glomerular endothelial cells and podocytes in patients with membranous nephropathy

与膜性肾病患者的肾小球内皮细胞和足细胞反应的自身抗体

2025-12-090
OAAI
Sparsentan reduces glomerular dysfunction and proteinuria in a rat model of serum-factor-induced nephrotic syndrome

Sparsentan可减轻血清因子诱导的肾病综合征大鼠模型中的肾小球功能障碍和蛋白尿。

2025-10-010
OAAI
Matrix metalloproteinase-9 mediates endothelial glycocalyx degradation and correlates with severity of hemorrhagic fever with renal syndrome

基质金属蛋白酶-9介导内皮糖萼降解,并与肾综合征出血热严重程度相关

2025-08-050
OA
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes (vol 23, 50, 2024)
2024-02-200
OAAI
Heparanase inhibition as a systemic approach to protect the endothelial glycocalyx and prevent microvascular complications in diabetes
2024-02-012
OAAI
Shiga toxin targets the podocyte causing hemolytic uremic syndrome through endothelial complement activation

志贺毒素通过内皮补体激活靶向足细胞引起溶血性尿毒症综合征

MED
IF11.8
2023-11-013
OAAI
Mineralocorticoid receptor antagonism in diabetes reduces albuminuria by preserving the glomerular endothelial glycocalyx
2023-03-0815
OA
Reduced Glomerular Filtration in Diabetes Is Attributable to Loss of Density and Increased Resistance of Glomerular Endothelial Cell Fenestrations
2022-06-0115
OA
Minimal Change Disease Is Associated With Endothelial Glycocalyx Degradation and Endothelial Activation
2022-04-0118
OAAI